Do bisphosphonates inhibit direct fracture healing?
- 1 September 2013
- journal article
- Published by British Editorial Society of Bone & Joint Surgery in The Bone & Joint Journal
- Vol. 95-B (9) , 1263-1268
Abstract
Fracture repair occurs by two broad mechanisms: direct healing, and indirect healing with callus formation. The effects of bisphosphonates on fracture repair have been assessed only in models of indirect fracture healing. A rodent model of rigid compression plate fixation of a standardised tibial osteotomy was used. Ten skeletally mature Sprague–Dawley rats received daily subcutaneous injections of 1 µg/kg ibandronate (IBAN) and ten control rats received saline (control). Three weeks later a tibial osteotomy was rigidly fixed with compression plating. Six weeks later the animals were killed. Fracture repair was assessed with mechanical testing, radiographs and histology. The mean stress at failure in a four-point bending test was significantly lower in the IBAN group compared with controls (8.69 Nmm-2 (sd 7.63) vs 24.65 Nmm-2 (sd 6.15); p = 0.017). On contact radiographs of the extricated tibiae the mean bone density assessment at the osteotomy site was lower in the IBAN group than in controls (3.7 mmAl (sd 0.75) vs 4.6 mmAl (sd 0.57); p = 0.01). In addition, histological analysis revealed progression to fracture union in the controls but impaired fracture healing in the IBAN group, with predominantly cartilage-like and undifferentiated mesenchymal tissue (p = 0.007). Bisphosphonate treatment in a therapeutic dose, as used for risk reduction in fragility fractures, had an inhibitory effect on direct fracture healing. We propose that bisphosphonate therapy not be commenced until after the fracture has united if the fracture has been rigidly fixed and is undergoing direct osteonal healing. Cite this article: Bone Joint J 2013;95-B:1263–8.Keywords
This publication has 30 references indexed in Scilit:
- The development of a novel model of direct fracture healing in the ratBone & Joint Research, 2012
- Evidence for anti-osteoporosis therapy in acute fracture situations—Recommendations of a multidisciplinary workshop of the International Society for Fracture RepairBone, 2010
- Three Years of Alendronate Treatment Results in Similar Levels of Vertebral Microdamage as After One Year of TreatmentJournal of Bone and Mineral Research, 2007
- Optimal Timing of a Single Dose of Zoledronic Acid to Increase Strength in Rat Fracture RepairJournal of Bone and Mineral Research, 2007
- Subtrochanteric insufficiency fractures in patients on alendronate therapyThe Journal of Bone and Joint Surgery. British volume, 2007
- Osteoclastic activity begins early and increases over the course of bone healingBone, 2006
- A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repairJournal of Orthopaedic Research, 2005
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Long-Term Administration of Clodronate Does Not Prevent Fracture Healing in RatsClinical Orthopaedics and Related Research, 2003
- Raloxifene, Estrogen, and Alendronate Affect the Processes of Fracture Repair Differently in Ovariectomized RatsJournal of Bone and Mineral Research, 2002